Stock Updates

How has Teva Pharmaceutical Industries Limited:(NYSE:TEVA) performed recently?

Teva Pharmaceutical Industries Limited (NYSE: TEVA) is a large market cap stock with a market cap of 53949.53. It is in the Drug Manufacturers – Other industry and sector Healthcare, with a current P/E of 34.65, a forward P/E of 8.72 and EPS of 1.5. At a stock price of 51.9 (-0.10%) it has a dividend yield of 2.62%.

EPS growth for the last five years have been -13.10%, more recently this last year it has grown by -48.90%. The next year growth is going to be about 13.09% and more long-term 5.70% after five years. EPS growth quarter over quarter is -67.40%. Sales growth for the past five years have been 4.00% and sales growth quarter over quarter is 1.40%.

For performance, Teva Pharmaceutical Industries Limited the past week has seen a gain of 1.68%. For the last month performance for Teva Pharmaceutical Industries Limited is -2.89%. While the last quarter is 0.05% and half year, -1.71%. Finally for the year, performance is -17.61%.

The 52-week high for Teva Pharmaceutical Industries Limited, is at -20.51%, and for the 52-week low it comes to a value of 8.80%. The 20-day simple moving average is -1.33% and -6.43% for the 200-day simple moving average.

Volatility for the week is at 2.02%, and for the month it is 2.08%. Teva Pharmaceutical Industries Limited, has a target price of 68.77.

In terms of debt, long term debt/equity is 0.27, and for total debt/equity Teva Pharmaceutical Industries Limited has 0.36. The gross margin is 57.70%, while operating margin is 17.70%, the profit margin is 6.90%. The current ratio is 1.3 and the quick ratio is 1.

Insider ownership is at 2.70%, with instituitional ownership at 59.20%. Teva Pharmaceutical Industries Limited has a payout ratio of 67.50%. With the total shares outstanding coming to 1039.49. The shares float is 1014.36, with the float short at 1.36%, with short ratio coming to 2.33.

In terms of returns, the return on assets see Teva Pharmaceutical Industries Limited, get 2.50%, with its returns on investment at 5.70%. Return on equity is 4.90%. So will the investors see the target price of 68.77, reached soon?

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.


About the author

Mark Hines

Leave a Comment